header

Clinicians' Biosecurity News* Archive: 2012
                     

  • 02/17/2012. Genetic Susceptibility to Anthrax: A new study suggests that susceptibility to anthrax toxins may be genetic and variable. The results shed light on the relationship between anthrax toxins and human cell receptors, with potential implications for next generation countermeasure development.
  • 02/03/2012. Influenza B and Severe Disease: Influenza B caused 38% of pediatric flu deaths in the 2010-11 influenza season. A CDC team analyzed autopsy data from the decade between May 2000 and February 2010 to better understand the pathology of fatal cases of influenza B.
  • 01/20/2012. Totally Drug Resistant Tuberculosis: The treatment of TB is complicated by drug resistance--first single drug resistance emerged, then MDR-TB in the 1990s, followed by XDR-TB in 2001, and TDR-TB in 2007. A recent report detailing 4 cases of TDR-TB in India is the third report since 2007.
  • 01/17/2012. Clinicians' Biosecurity Resource App Now Available: The CBR is a healthcare provider’s guide to clinical features, diagnostic tests, treatments, and infection control measures for the most dangerous potential biothreats. It is available for download at no charge from the iTunes App store.
  • 01/06/2012. Statins and Influenza: Results of a recent multistate retrospective analysis of the effect of statins on 30-day mortality of laboratory-confirmed influenza provides new evidence of the benefits of statins in reducing inflammatory changes associated with influenza.